Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia

• Published in: Indian journal of ophthalmology Vol. 68; no. 4; pp. 653 - 656
• Main Authors: Kothari, Mihir, Modak, Mohini, Khan, Heena, Jahan, Shairin, Solanki, Meghna, Rathod, Vivek
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.04.2020; Medknow Publications and Media Pvt. Ltd; Medknow Publications & Media Pvt. Ltd; Wolters Kluwer - Medknow; Wolters Kluwer Medknow Publications
• Subjects: Accommodation, Ocular; anticholinergic; Atropine; Atropine - adverse effects; Care and treatment; Case Reports; Case studies; Child; Child, Preschool; Consent; Convergence; convergence excess; Convergence, Ocular; Diagnosis; Dosage and administration; Drug therapy; Esotropia; Esotropia - chemically induced; Esotropia - diagnosis; Esotropia - surgery; Exotropia - chemically induced; Exotropia - diagnosis; Exotropia - surgery; Humans; Oculomotor Muscles - surgery; Ophthalmic agents; Ophthalmic Solutions; Patients; progressive myopia; Strabismus; Surgery; Tropicamide; India; progressive myopia; convergence excess; Anticholinergic; atropine; esotropia
• ISSN: 0301-4738; 1998-3689
• DOI: 10.4103/ijo.IJO_1243_19

To report convergence excess esotropia (CEET) following 0.01% atropine eye drops (Low dose atropine [LDA]). Children who developed CEET that resolved promptly after discontinuation of LDA are described. Three myopes aged 5.3 ± 1.2 years and mean sphere -4.5D were included. All were operated for intermittent exotropia earlier. Mean esotropia was +28.3PD for near and 10.6PD for distance. LDA induced high AC/A ratio and fusion normalized in 3 weeks after discontinuation of LDA. LDA should be used with caution in patients with esophoria or previously operated for intermittent exotropia. Any evidence of the emergence of a CEET should warrant discontinuation of LDA.